deuterated prasugrel (DeuteRx)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Namedeuterated prasugrel (DeuteRx)
Drug Alias Namedeuterated prasugrel (Deuteria Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPurinergic receptor P2Y12 antagonists
TargetsPurinergic receptor P2Y12
Therapy Area/IndicationsAcute Coronary Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDeuteria Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDeuteria Pharmaceuticals IncDeuterx
Active IndicationsN/A
Inactive IndicationsAcute Coronary Syndrome

Other Information

ATC CodeN/A
Related LinksN/A